-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Hold on TransMedics Group, Lowers Price Target to $85

Benzinga·05/06/2026 17:43:43
Listen to the news
Stifel analyst Thomas Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and lowers the price target from $130 to $85.